Credit Suisse Upgrades The Medicines Company (MDCO) to Outperform
Tweet Send to a Friend
Credit Suisse upgraded The Medicines Company (NASDAQ: MDCO) from Neutral to Outperform with a price target of $30 (from $27) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
